LRP1B and liver cancer: Furthermore, liver cancer with LRP1B or TP53 mutations have been correlated with high TMB and patients with any of these two gene mutations were more likely to respond to immunotherapy although LRP1B or TP53 mutations generally serve as poor prognostic factors (68).